Jane Street Group, LLC Atai Life Sciences N.V. Transaction History

Jane Street Group, LLC

  • $384 Billion
  • Q1 2025

A detailed history of Jane Street Group, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Jane Street Group, LLC holds 34,523 shares of ATAI stock, worth $70,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,523
Previous 34,523 -0.0%
Holding current value
$70,772
Previous $46,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$1.33 - $2.55 $87,916 - $168,562
-66,103 Reduced 65.69%
34,523 $46,000
Q4 2024

Feb 14, 2025
BUY
$1.06 - $1.78 $106,663 - $179,114
100,626 New
100,626 $133,000
Q2 2024

Aug 14, 2024
SELL
$1.27 - $2.6 $22,256 - $45,565
-17,525 Reduced 49.66%
17,765 $23,000
Q1 2024

May 15, 2024
SELL
$1.5 - $2.19 $184,545 - $269,435
-123,030 Reduced 77.71%
35,290 $69,000
Q4 2023

Feb 14, 2024
BUY
$1.04 - $1.55 $144,349 - $215,136
138,798 Added 710.98%
158,320 $223,000
Q3 2023

Nov 14, 2023
BUY
$1.27 - $2.28 $24,792 - $44,510
19,522 New
19,522 $25,000
Q1 2023

May 15, 2023
BUY
$1.17 - $2.7 $3,008 - $6,941
2,571 Added 14.31%
20,532 $37,000
Q4 2022

Feb 14, 2023
SELL
$2.38 - $3.55 $17,581 - $26,223
-7,387 Reduced 29.14%
17,961 $47,000
Q3 2022

Nov 14, 2022
BUY
$3.14 - $4.87 $79,592 - $123,444
25,348 New
25,348 $84,000
Q3 2022

Nov 14, 2022
BUY
$3.14 - $4.87 $79,592 - $123,444
25,348 New
25,348 $84,000
Q2 2022

Aug 16, 2022
SELL
$3.03 - $5.32 $550,120 - $965,888
-181,558 Closed
0 $0
Q1 2022

May 17, 2022
SELL
$4.66 - $7.66 $25,075 - $41,218
-5,381 Reduced 2.88%
181,558 $924,000
Q4 2021

Feb 15, 2022
BUY
$6.82 - $17.8 $1.27 Million - $3.33 Million
186,939 New
186,939 $1.43 Million

Others Institutions Holding ATAI

# of Institutions
98
Shares Held
23.7M
Call Options Held
351K
Put Options Held
170K
View Full List

About ATAI Life Sciences N.V.

ATAI Quotes by TradingView
  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $340M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email